Back to search

Article

Exogenous BMP9 therapy ameliorates primary graft dysfunction post lung transplantation

2025-10-01

Abstract excerpt

<h4>ABSTRACT</h4> Primary graft dysfunction (PGD) is a leading cause of early mortality after lung transplantation and is driven by ischemia-reperfusion injury (IRI), which destabilizes the pulmonary endothelium. Bone morphogenetic protein 9 (BMP9), a vascular quiescence factor of the TGF superfamily, maintains endothelial homeostasis through ALK-1/BMPR2-mediated signaling. Herein, this work identified a previous...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d948ab06-29a8-52aa-bec1-2ab1139c68ec
DOI
10.1101/2025.09.30.679530
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Exogenous BMP9 therapy ameliorates primary graft dysfunction post lung transplantationDOI 10.1101/2025.09.30.679530
Select a neighboring publication to make it the new centre.